Global B-Cell Non-Hodgkin's Lymphoma Drug Supply, Demand and Key Producers, 2024-2030
Page: 111
Published Date: 18 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global B-Cell Non-Hodgkin's Lymphoma Drug market size is expected to reach $ 12940 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.
This report studies the global B-Cell Non-Hodgkin's Lymphoma Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for B-Cell Non-Hodgkin's Lymphoma Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of B-Cell Non-Hodgkin's Lymphoma Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global B-Cell Non-Hodgkin's Lymphoma Drug total market, 2019-2030, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: B-Cell Non-Hodgkin's Lymphoma Drug total market, key domestic companies and share, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug revenue by player and market share 2019-2024, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by Type, CAGR, 2019-2030, (USD Million)
Global B-Cell Non-Hodgkin's Lymphoma Drug total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global B-Cell Non-Hodgkin's Lymphoma Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma and Teva, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World B-Cell Non-Hodgkin's Lymphoma Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global B-Cell Non-Hodgkin's Lymphoma Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global B-Cell Non-Hodgkin's Lymphoma Drug Market, Segmentation by Type
Oral
Injection
Global B-Cell Non-Hodgkin's Lymphoma Drug Market, Segmentation by Application
Hospital
Retail Pharmacy
Other
Companies Profiled:
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma
Key Questions Answered
1. How big is the global B-Cell Non-Hodgkin's Lymphoma Drug market?
2. What is the demand of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
3. What is the year over year growth of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
4. What is the total value of the global B-Cell Non-Hodgkin's Lymphoma Drug market?
5. Who are the major players in the global B-Cell Non-Hodgkin's Lymphoma Drug market?
Table of Contents
1 Supply Summary
1.1 B-Cell Non-Hodgkin's Lymphoma Drug Introduction
1.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size & Forecast (2019 & 2023 & 2030)
1.3 World B-Cell Non-Hodgkin's Lymphoma Drug Total Market by Region (by Headquarter Location)
1.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.3 China B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.5 Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.6 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.7 ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.3.8 India B-Cell Non-Hodgkin's Lymphoma Drug Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 B-Cell Non-Hodgkin's Lymphoma Drug Major Market Trends
2.1 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.2 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region
2.2.1 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024)
2.2.2 World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2025-2030)
2.3 United States B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.4 China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.5 Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.6 Japan B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.7 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.8 ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
2.9 India B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030)
3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for B-Cell Non-Hodgkin's Lymphoma Drug in 2023
3.2.3 Global Concentration Ratios (CR8) for B-Cell Non-Hodgkin's Lymphoma Drug in 2023
3.3 B-Cell Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
3.4 B-Cell Non-Hodgkin's Lymphoma Drug Market: Overall Company Footprint Analysis
3.4.1 B-Cell Non-Hodgkin's Lymphoma Drug Market: Region Footprint
3.4.2 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
3.4.3 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison
4.2.1 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2019-2024
4.3.1 United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)
4.4 China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Market Share, 2019-2024
4.4.1 China Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)
4.5 Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies and Market Share, 2019-2024
4.5.1 Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024)
5.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2019-2024)
5.3.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2025-2030)
5.3.3 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2019-2030)
6.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2024)
6.3.2 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2025-2030)
6.3.3 World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2030)
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.1.4 Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.2.4 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 TG Therapeutics
7.3.1 TG Therapeutics Details
7.3.2 TG Therapeutics Major Business
7.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.3.4 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 TG Therapeutics Recent Developments/Updates
7.3.6 TG Therapeutics Competitive Strengths & Weaknesses
7.4 Bayer
7.4.1 Bayer Details
7.4.2 Bayer Major Business
7.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.4.4 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Bayer Recent Developments/Updates
7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 Secura Bio
7.5.1 Secura Bio Details
7.5.2 Secura Bio Major Business
7.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.5.4 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Secura Bio Recent Developments/Updates
7.5.6 Secura Bio Competitive Strengths & Weaknesses
7.6 Epizyme
7.6.1 Epizyme Details
7.6.2 Epizyme Major Business
7.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.6.4 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Epizyme Recent Developments/Updates
7.6.6 Epizyme Competitive Strengths & Weaknesses
7.7 Eisai
7.7.1 Eisai Details
7.7.2 Eisai Major Business
7.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.7.4 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Eisai Recent Developments/Updates
7.7.6 Eisai Competitive Strengths & Weaknesses
7.8 Acrotech Biopharma
7.8.1 Acrotech Biopharma Details
7.8.2 Acrotech Biopharma Major Business
7.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.8.4 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Acrotech Biopharma Recent Developments/Updates
7.8.6 Acrotech Biopharma Competitive Strengths & Weaknesses
7.9 Teva
7.9.1 Teva Details
7.9.2 Teva Major Business
7.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.9.4 Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Teva Recent Developments/Updates
7.9.6 Teva Competitive Strengths & Weaknesses
7.10 Eagle Pharmaceuticals
7.10.1 Eagle Pharmaceuticals Details
7.10.2 Eagle Pharmaceuticals Major Business
7.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.10.4 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Eagle Pharmaceuticals Recent Developments/Updates
7.10.6 Eagle Pharmaceuticals Competitive Strengths & Weaknesses
7.11 MundiPharma
7.11.1 MundiPharma Details
7.11.2 MundiPharma Major Business
7.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
7.11.4 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 MundiPharma Recent Developments/Updates
7.11.6 MundiPharma Competitive Strengths & Weaknesses
8.1 B-Cell Non-Hodgkin's Lymphoma Drug Industry Chain
8.2 B-Cell Non-Hodgkin's Lymphoma Drug Upstream Analysis
8.3 B-Cell Non-Hodgkin's Lymphoma Drug Midstream Analysis
8.4 B-Cell Non-Hodgkin's Lymphoma Drug Downstream Analysis
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key B-Cell Non-Hodgkin's Lymphoma Drug Players in 2023
Table 12. World B-Cell Non-Hodgkin's Lymphoma Drug Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global B-Cell Non-Hodgkin's Lymphoma Drug Company Evaluation Quadrant
Table 14. Head Office of Key B-Cell Non-Hodgkin's Lymphoma Drug Player
Table 15. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
Table 16. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
Table 17. B-Cell Non-Hodgkin's Lymphoma Drug Mergers & Acquisitions Activity
Table 18. United States VS China B-Cell Non-Hodgkin's Lymphoma Drug Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
Table 23. China Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
Table 26. Rest of World Based B-Cell Non-Hodgkin's Lymphoma Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share (2019-2024)
Table 29. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2019-2024) & (USD Million)
Table 31. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type (2025-2030) & (USD Million)
Table 32. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2019-2024) & (USD Million)
Table 34. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application (2025-2030) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 38. Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Gilead Sciences Basic Information, Area Served and Competitors
Table 42. Gilead Sciences Major Business
Table 43. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 44. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Gilead Sciences Recent Developments/Updates
Table 46. Gilead Sciences Competitive Strengths & Weaknesses
Table 47. TG Therapeutics Basic Information, Area Served and Competitors
Table 48. TG Therapeutics Major Business
Table 49. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 50. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. TG Therapeutics Recent Developments/Updates
Table 52. TG Therapeutics Competitive Strengths & Weaknesses
Table 53. Bayer Basic Information, Area Served and Competitors
Table 54. Bayer Major Business
Table 55. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 56. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. Bayer Recent Developments/Updates
Table 58. Bayer Competitive Strengths & Weaknesses
Table 59. Secura Bio Basic Information, Area Served and Competitors
Table 60. Secura Bio Major Business
Table 61. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 62. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Secura Bio Recent Developments/Updates
Table 64. Secura Bio Competitive Strengths & Weaknesses
Table 65. Epizyme Basic Information, Area Served and Competitors
Table 66. Epizyme Major Business
Table 67. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 68. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. Epizyme Recent Developments/Updates
Table 70. Epizyme Competitive Strengths & Weaknesses
Table 71. Eisai Basic Information, Area Served and Competitors
Table 72. Eisai Major Business
Table 73. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 74. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. Eisai Recent Developments/Updates
Table 76. Eisai Competitive Strengths & Weaknesses
Table 77. Acrotech Biopharma Basic Information, Area Served and Competitors
Table 78. Acrotech Biopharma Major Business
Table 79. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 80. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Acrotech Biopharma Recent Developments/Updates
Table 82. Acrotech Biopharma Competitive Strengths & Weaknesses
Table 83. Teva Basic Information, Area Served and Competitors
Table 84. Teva Major Business
Table 85. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 86. Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Teva Recent Developments/Updates
Table 88. Teva Competitive Strengths & Weaknesses
Table 89. Eagle Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Eagle Pharmaceuticals Major Business
Table 91. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 92. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. Eagle Pharmaceuticals Recent Developments/Updates
Table 94. MundiPharma Basic Information, Area Served and Competitors
Table 95. MundiPharma Major Business
Table 96. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Services
Table 97. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 98. Global Key Players of B-Cell Non-Hodgkin's Lymphoma Drug Upstream (Raw Materials)
Table 99. B-Cell Non-Hodgkin's Lymphoma Drug Typical Customers
List of Figure
Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Picture
Figure 2. World B-Cell Non-Hodgkin's Lymphoma Drug Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World B-Cell Non-Hodgkin's Lymphoma Drug Total Market Size (2019-2030) & (USD Million)
Figure 4. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company B-Cell Non-Hodgkin's Lymphoma Drug Revenue (2019-2030) & (USD Million)
Figure 13. B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 16. World B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region (2019-2030)
Figure 17. United States B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. India B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of B-Cell Non-Hodgkin's Lymphoma Drug by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for B-Cell Non-Hodgkin's Lymphoma Drug Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for B-Cell Non-Hodgkin's Lymphoma Drug Markets in 2023
Figure 27. United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type in 2023
Figure 31. Oral
Figure 32. Injection
Figure 33. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Type (2019-2030)
Figure 34. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World B-Cell Non-Hodgkin's Lymphoma Drug Market Size Market Share by Application in 2023
Figure 36. Hospital
Figure 37. Retail Pharmacy
Figure 38. Other
Figure 39. B-Cell Non-Hodgkin's Lymphoma Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Gilead Sciences TG Therapeutics Bayer Secura Bio Epizyme Eisai Acrotech Biopharma Teva Eagle Pharmaceuticals MundiPharma
Related Reports
09 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
